Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Konkordia West | Pharma | 41.6% | 93rd pct | 110 |
| Medeksporti | Pharma | 36.8% | 87th pct | 110 |
| JMP | Pharma | 20.8% | 62nd pct | 110 |
| Medinservi Company | Pharma | 17.6% | 53rd pct | 110 |
| Net Pharma Sakartvelo | Pharma | — | no FY data | 110 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Line item | Konkordia West | JMP | Medinservi Company | Medeksporti | Net Pharma Sakartvelo |
|---|---|---|---|---|---|
| Total Current Assets | 7,583 | 3,317 | 10,392 | 10,561 | — |
| Total Non-Current Assets | 10,290 | 2,422 | 10,104 | 7 | — |
| TOTAL ASSETS | 17,873 | 5,740 | 20,496 | 10,568 | — |
| Total Current Liabilities | 309 | 876 | 822 | 7,054 | — |
| Total Non-Current Liabilities | 0 | 233 | 0 | 0 | — |
| TOTAL LIABILITIES | 309 | 1,110 | 822 | 7,054 | — |
| Total Equity | 17,563 | 4,630 | 19,674 | 3,514 | — |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | — |
| Total Debt | 0 | 233 | 0 | 0 | — |
| Cash & Equivalents | 192 | 317 | 8,697 | 110 | — |
| Net Debt | -192 | -83 | -8,697 | -110 | — |
Not every picked company reports every selected year — FY2024: no filing for Net Pharma Sakartvelo. Those cells are left blank (no filing), not zero.